Zydus Cadila gets tentative nod from USFDA to market Parkinson's disease drug
Posted by
www.biotecnika.org
The company has received tentative approval from the United States
Food and Drug Administration (USFDA) to market the capsules in the
strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and
61.25 mg/245 mg, Zydus Cadila said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-tentative-nod-from-usfda-to-market-parkinsons-disease-drug/articleshow/77299625.cms
Subscribe to:
Post Comments (Atom)
Post a Comment